Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Japan’s PMDA Approves Aurion Biotech’s NDA
Aurion Biotech announced that it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its pioneering cell therapy, VyznovaTM, designed for treating bullous keratopathy of the cornea. According to the company, this represents the world’s first…
VSY’s SVT Technology Secures Patent Grant in the US
Andreas C. Kühnel, Managing Director at VSY Biotechnology announced that the company’s innovative Sinusoidal Vision Technology (SVT®) has received its U.S. patent from the United States Patent and Trademark Office. This significant milestone is a testament to the company’s commitment…
Tiny Eye Implant: A Diabetes Treatment Option
In Sweden, researchers have created a microscale device designed for implantation in the eye, opening up new paths for cell-based treatments for conditions like diabetes. Developed by a team from KTH Royal Institute of Technology and Karolinska Institutet, this 3D-printed…
XPANCEO Raises $40M for AR Vision Contact Lenses
XPANCEO, a deep tech startup, has secured $40 million in seed funding to introduce groundbreaking contact lenses with augmented reality (AR) vision features. These funds will be strategically channeled into the development of the next prototype, consolidating multiple features within…
ICTER’s New Imaging Method for Early Diagnosis
Optical coherence tomography (OCT) stands as one of the most foundational and accurate tests for diagnosing eye diseases. While it excels in a detailed examination of individual eye structures, its effectiveness diminishes when applied to the early detection of subtle…
Herpes Zoster Ophthalmicus | OBN
Herpes Zoster Ophthalmicus (HZO), commonly known as shingles, is a viral disease characterized by a unilateral painful skin rash in one or more dermatome distributions of the fifth cranial nerve (trigeminal nerve), shared by the eye and ocular adnexa. Herpes…
VSY Biotechnology AcrivaUD Trinova Pro C Pupil Adaptive® I OBN
VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, is readying to share the first clinical experiences of AcrivaUD Trinova Pro C Pupil Adaptive®, the first and only trifocal IOL that combines patented enhanced Sinusoidal Vision Technology…
What Is Diffuse Lamellar Keratitis and How to Manage It
What is Diffuse Lamellar Keratitis (DLK)? Diffuse Lamellar Keratitis, commonly referred to as DLK, is an inflammatory condition that can occur following LASIK (Laser-Assisted In Situ Keratomileusis) eye surgery. DLK is characterized by inflammation in the corneal flap, which is…
What Is Ocular Toxoplasmosis and How to Manage It
What Is Ocular Toxoplasmosis? Ocular toxoplasmosis is an eye infection caused by the Toxoplasma gondii parasite. It is a form of toxoplasmosis that specifically affects the eyes, often leading to inflammation of the retina, and potentially causing vision problems, including…
Pros and Cons of Light Adjustable Lens (LAL)
Light Adjustable Lens (LAL) technology is a groundbreaking advancement in the field of ophthalmology, offering a novel approach to vision correction and the treatment of cataracts. Unlike traditional intraocular lenses that are permanently fixed in their refractive power, LALs can…